Procter & Gamble Company (PG)
Return on equity (ROE)
| Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 15,495,000 | 15,480,000 | 14,318,000 | 14,880,000 | 15,127,000 | 14,770,000 | 15,235,000 | 14,653,000 | 14,321,000 | 14,279,000 | 14,569,000 | 14,742,000 | 14,596,000 | 14,510,000 | 14,141,000 | 14,306,000 | 14,200,000 | 13,848,000 | 13,711,000 | 13,027,000 |
| Total stockholders’ equity | US$ in thousands | 52,272,000 | 51,168,000 | 51,840,000 | 50,286,000 | 50,058,000 | 48,534,000 | 47,692,000 | 46,777,000 | 45,140,000 | 44,455,000 | 44,075,000 | 46,589,000 | 45,478,000 | 44,618,000 | 46,111,000 | 46,378,000 | 46,596,000 | 48,181,000 | 48,182,000 | 46,521,000 |
| ROE | 29.64% | 30.25% | 27.62% | 29.59% | 30.22% | 30.43% | 31.94% | 31.33% | 31.73% | 32.12% | 33.06% | 31.64% | 32.09% | 32.52% | 30.67% | 30.85% | 30.47% | 28.74% | 28.46% | 28.00% |
March 31, 2025 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $15,495,000K ÷ $52,272,000K
= 29.64%
The analysis of Procter & Gamble Company's return on equity (ROE) over the period from June 2020 to March 2025 indicates a generally stable performance with notable fluctuations reflecting operational and market dynamics.
Initially, the ROE showed a gradual upward trend, starting at approximately 28.00% in June 2020 and increasing to a peak of around 33.06% as of September 2022. This upward momentum suggests improving profitability relative to shareholders’ equity, potentially driven by effective operational management and favorable market conditions during this period.
Between September 2022 and December 2023, the ROE maintained a level generally above 30%, with minor declines and fluctuations, peaking at 32.52% in December 2021 before settling around 31.33% in June 2023. These levels demonstrate the company's consistent ability to generate strong returns on shareholders' invested capital, reflective of solid operational efficiency and profit margins.
However, following this peak, the ROE experienced a downward trend, dropping to approximately 27.62% by September 2024. This decline may be indicative of increased competition, higher costs, or shifts in revenue growth. Despite this, there was a slight recovery observed in December 2024, with the ROE rising back up to around 30.25%, before a modest decrease to approximately 29.64% in March 2025.
Throughout the analyzed period, the ROE exhibits a pattern of growth into 2022, stabilization at elevated levels, followed by a modest decline in 2024. These movements suggest a period of strong profitability and efficient capital utilization that faced some headwinds in recent quarters, yet remains relatively robust. The overall trend underscores the company's capacity to generate shareholder value, albeit with some variability likely associated with macroeconomic pressures, market competition, or internal strategic adjustments.
See also:
Procter & Gamble Company Return on Equity (ROE) (Quarterly Data)